RT Book, Section A1 Nast, Cynthia C. A1 Adler, Sharon G. A2 Lerma, Edgar V. A2 Berns, Jeffrey S. A2 Nissenson, Allen R. SR Print(0) ID 6336929 T1 Chapter 34. Thrombotic Microangiopathies T2 CURRENT Diagnosis & Treatment: Nephrology & Hypertension YR 2009 FD 2009 PB The McGraw-Hill Companies PP New York, NY SN 978-0-07-144787-4 LK accessmedicine.mhmedical.com/content.aspx?aid=6336929 RD 2024/11/13 AB The thrombotic microangiopathies (TMAs) are classified together due to their overlapping clinical and morphologic findings. Their major clinical manifestations include hemolytic anemia, microvascular thrombosis, and thrombocytopenia. Most TMAs have renal involvement with similar morphologic changes in the kidney reflecting the vasculopathy these lesions share. There are a number of underlying etiologic factors inducing TMA including systemic diseases, infection, and medications, which are summarized in Table 34–1.